Independence blue cross pay 225m medicare advantage inaccurate diagnoses allegations

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 05 Oct, 16:16 UTC

The settlement resolves allegations from 2017 to 2021 that the company submitted “inaccurate and untruthful” diagnoses data to CMS.